title: ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up.
abstract: The first joint European Society for Medical Oncology (ESMO), European SocieTy for Radiotherapy & Oncology (ESTRO) and European Society of Gynaecological Oncology (ESGO) consensus conference on endometrial cancer was held on 11-13 December 2014 in Milan, Italy, and comprised a multidisciplinary panel of 40 leading experts in the management of endometrial cancer. Before the conference, the expert panel prepared three clinically-relevant questions about endometrial cancer relating to the following four areas: prevention and screening, surgery, adjuvant treatment and advanced and recurrent disease. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the consensus conference, the panel developed recommendations for each specific question and a consensus was reached. Results of this consensus conference, together with a summary of evidence supporting each recommendation, are detailed in this article. All participants have approved this final article.
authors.affiliation: *Division of Medical Gynecologic Oncology, European Institute of Oncology and University of Milan-Bicocca, Milan, Italy; †Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands; ‡Department of Gynecological Oncology, University Hospital Leuven, Leuven, Belgium and Center for Gynecological Oncology Amsterdam (CGOA), Antoni van Leeuwenhoek, Amsterdam, The Netherlands; §Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands; ∥Medical Oncology Department, GEICO and MD Anderson Cancer Center, Madrid, Spain; ¶Department of Oncology and Cancer Trials, UCL Cancer Institute, London, United Kingdom; #Department of Obstetrics and Gynecology, Innsbruck Medical University, Innsbruck, Austria; **Department of Radiotherapy, Leiden University Medical Center, Leiden, The Netherlands; ††Department of Surgery, Institut Bergonié, Bordeaux, France and Gynecology and Obstetrics Department, McGill University Health Centre, Montreal, Quebec, Canada; ‡‡Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; and §§Department of Medical Oncology, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland.
authors.forename: Nicoletta
authors.initials: N
authors.lastname: Colombo
authors.forename: Carien
authors.initials: C
authors.lastname: Creutzberg
authors.forename: Frederic
authors.initials: F
authors.lastname: Amant
authors.forename: Tjalling
authors.initials: T
authors.lastname: Bosse
authors.forename: Antonio
authors.initials: A
authors.lastname: González-Martín
authors.forename: Jonathan
authors.initials: J
authors.lastname: Ledermann
authors.forename: Christian
authors.initials: C
authors.lastname: Marth
authors.forename: Remi
authors.initials: R
authors.lastname: Nout
authors.forename: Denis
authors.initials: D
authors.lastname: Querleu
authors.forename: Mansoor Raza
authors.initials: MR
authors.lastname: Mirza
authors.forename: Cristiana
authors.initials: C
authors.lastname: Sessa
mesh_terms: D016889:Endometrial Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008495:Medical Oncology / Q000458:organization & administration / Q000592:standards; D017410:Practice Guidelines as Topic; D012955:Societies, Medical / Q000458:organization & administration / Q000592:standards